EFFECT OF HCV RNA SUPPRESSION DURING PEGINTERFERON ALFA-2A MAINTENANCE THERAPY ON CLINICAL OUTCOMES IN THE HALT-C TRIAL

BACKGROUND AND AIMS: The HALT-C trial demonstrated that low-dose peginterferon maintenance therapy was ineffective in preventing clinical outcomes in patients with chronic hepatitis C, advanced fibrosis and failure to achieve a sustained virologic response during lead-in phase treatment with standar...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shiffman, Mitchell L, Morishima, Chihiro, Dienstag, Jules L, Lindsay, Karen L, Hoefs, John C, Lee, William M, Wright, Elizabeth C., Naishadham, Deepa, Everson, Gregory T, Lok, Anna S, Di Bisceglie, Adrian M, Bonkovsky, Herbert L, Ghany, Marc G
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3774149/
https://ncbi.nlm.nih.gov/pubmed/19747918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2009.08.067
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires